Cite
HARVARD Citation
Badrising, S. et al. (2016). Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration‐resistant prostate cancer patients; a possible time relation. Prostate. 76 (1), pp. 32-40. [Online].